Skip to main content
Clinical Trials/NL-OMON44474
NL-OMON44474
Completed
N/A

Optimization of Cardiac Resynchronization Therapy with a Quadripolar Left Ventricular Lead - OPTICARE-QLV

niversitair Medisch Centrum Utrecht0 sites60 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic heart failure
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • Patients with an indication for Cardiac Resynchronization Therapy according to the current international evidence based guidelines for CRT (the 2013 European Society of Cardiology Guidelines for cardiac pacing and cardiac resynchronization therapy):
  • \- Chronic heart failure;
  • \- New York Heart Association functional class II, III, IV (ambulatory);
  • \- QRS duration \*120ms;
  • \- Left bundle branch block
  • \- Optimal pharmacological therapy;
  • \- Left ventricular ejection fraction \*35%.

Exclusion Criteria

  • \- Contraindications for implantation of a CRT device;
  • \- Age \<18 years or incapacitated adult;
  • \- Pregnancy (clarified in E5\);
  • \- Severe aortic valve stenosis with a valve area \<1,0 cm2 or aortic valve replacement in history;
  • \- Participation in another clinical study that prohibits any procedures other than standard.
  • \- Permanent atrial fibrillation or atrial fibrillation during CRT implantation;The exclusion criteria regarding the MRI are:
  • \- Lactation;
  • \- Documented allergic reaction to gadolinium;
  • \- Subjects with impaired renal function (severe renal insufficiency, GFR \< 30 ml/min/1\.73m2\);
  • \- Impossibility to undergo a MRI scan (determined by using the standard contraindications for MR imaging as used for clinical purposes).

Outcomes

Primary Outcomes

Not specified

Similar Trials